Showing results (181-190 of 408) with videos related to
Sort By:
Pageof 41
Blood|October 1, 2024
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutationsZhuoer Xie, Jenna Fernandez, Terra Lasho, et al.American Journal of Hematology|April 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.Leukemia & Lymphoma|September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.Cancer|June 11, 2008
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment GroupStephen M Ansell, David J Inwards, Kendrith M Rowland, et al.Blood Cancer Journal|January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphomaAlessia Castellino, Aung M Tun, Yucai Wang, et al.Blood|August 13, 2009
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cellsRyan A Wilcox, David A Wada, Steven C Ziesmer, et al.JCO Oncology Practice|February 26, 2024
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With LymphomaHuong L Truong, Jason N Barreto, Kristin C Mara, et al.Haematologica|August 30, 2023
Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapyZhuoer Xie, Terra Lasho, Arushi Khurana, et al.Leukemia & Lymphoma|August 5, 2011
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemiaClive S Zent, Brian J Smith, Zuhair K Ballas, et al.Redox Biology|August 9, 2020
Increased glutathione utilization augments tumor cell proliferation in Waldenstrom MacroglobulinemiaShahrzad Jalali, Jie Shi, Alex Buko, et al.Pageof 41